Two years after discontinuation of semaglutide (timepoint 3), 2 subjects reported occasional liquid stools, 2 experienced occasional nausea and dyspepsia and 1 had occasional bloating
The safety and effectiveness of Wegovy tablets have not been established in pediatric patients Geriatric: In the CV outcomes trial, patients 75 years reported more hip and pelvis fractures on Wegovy injection than placebo
Emerging research suggests GLP-1 receptor agonists may also influence inflammatory pathways indirectly through metabolic improvements
A 40-week clinical trial (SUSTAIN FORTE) was conducted at 125 outpatient clinics across 10 countries, which involved 961 adults with type 2 diabetes who had uncontrolled diabetes with metformin (with or without sulfonylurea)
This allows your body to adjust to the change in dosage while also giving yourself longer to form and solidify your new diet and exercise habits, which will be critical in maintaining your weight loss long-term
The Muscle Loss Factor Nobody Talks About There is a critical dimension of semaglutide duration that most sources overlook: the composition of the weight you lose matters enormously, and it directly affects how well you maintain results after stopping
